Volume 5, Number 1—February 1999
Synopsis
Using Monoclonal Antibodies to Prevent Mucosal Transmission of Epidemic Infectious Diseases
Larry Zeitlin*, Richard A. Cone*†, and Kevin J. Whaley*†
Table 3
Preventive vaccines or cures for major sexually transmitted disease pathogens
| Pathogen | Vaccine | Cure | DRSa |
|---|---|---|---|
| Chlamydia trachomatis | no | yes | |
| Haemophilus ducreyi | no | yes | X |
| Hepatitis B | yes | no | |
| Herpes simplex 1 and 2 | no | no | X |
| HIV-1 and 2 | no | no | X |
| Human papilloma virus (HPV) | no | yesb | |
| Neisseria gonorrhoeae | no | yes | X |
| Treponema pallidum | no | yes | |
| Trichomonas vaginalis | no | yes | X |
aDrug-resistant strains reported.
bSurgical removal of HPV-infected tissue is performed.HPV-related cervical cancer identified early has a high cure rate; however, in the United States, for every three new cases, there is approximately one death (117).
